Replacing what’s lost: a new era of stem cell therapy for Parkinson’s disease
Abstract Background Stem cells hold tremendous promise for regenerative medicine because they can be expanded infinitely, giving rise to large numbers of differentiated cells required for transplantation. Stem cells can be derived from fetal sources, embryonic origins (embryonic stem cells or ESCs)...
Main Authors: | Yong Fan, Winanto, Shi-Yan Ng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | Translational Neurodegeneration |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40035-019-0180-x |
Similar Items
-
Toward the realization of cardiac regenerative medicine using pluripotent stem cells
by: Yoshikazu Kishino, et al.
Published: (2020-01-01) -
Prospects and challenges of induced pluripotent stem cells in equine health
by: Francesc Xavier eDonadeu, et al.
Published: (2015-11-01) -
Human Induced Pluripotent Stem Cell-Derived Exosomes as a New Therapeutic Strategy for Various Diseases
by: Aline Yen Ling Wang
Published: (2021-02-01) -
Insights into GBA Parkinson's disease pathology and therapy with induced pluripotent stem cell model systems
by: Pascale Baden, et al.
Published: (2019-07-01) -
Urine-Derived Stem Cells: Applications in Regenerative and Predictive Medicine
by: Guida Bento, et al.
Published: (2020-02-01)